M&A Healthcare Advisors Featured in Axial IB 2022 Annual Review
Andre Ulloa, partner at M&A Healthcare Advisors, was featured in a recent Levin article discussing M&A trends in specialty pharmacy.
The Top 50 Lower Middle Market Healthcare Investors & M&A Advisors [2022]
M&A Healthcare Advisors Named to Axial's Top 50 Lower Middle Market Healthcare Investors & M&A Advisors [2022]
Axial Names M&A Healthcare Advisors as “Top 50 Lower Middle Market Healthcare Investor”
M&A Healthcare Advisors, a boutique M&A advisory firm focused on middle-lower markets, is pleased to be named to Axial’s list of the “The Top 50 Lower Middle Market Healthcare Investors & M&A Advisors.”
M&A Data Show Upward Spike in Industry Transactions for Q2 and Q3
Andre Ulloa of M&A Healthcare Advisors discusses healthcare M&A trends in the November 2021 issue of Home Health Line.
Healthcare Hullabaloo
Healthcare M&A activity has seen a hearty uptick this year, making it an attractive — and exhausting — space for advisors bent on helping sellers pilot through the complicated deal-making process.